September 3, 2025
Covering Life Sciences Drugs, Diagnostics, Devices, Digital Health
* may need subscription to view
Science Attracts Attention. Strategy Secures Funding. Corval helps your quickly build a clear, accurate financial story that aligns with your milestones to win stakeholder confidence. Explore now >>

Press Releases

  • Amneal Pharmaceuticals: Launches First-of-Its-Kind Multichambered Bag for Oncology With TEPADINA (Thiotepa) 200 mg More
  • Cognition Therapeutics: Study of Zervimesine (CT1812) in Early Alzheimer’s Disease Reaches 75% Enrollment Target More
  • electroCore: Appoints Elena Bonfiglioli to Board of Directors More
  • GRIN Therapeutics: Multiple Clinical Development Updates for Radiprodil at 2025 ILAE International Epilepsy Congress More
  • HITLAB: Welcomes Dr. Fernando Gómez-Baquero as New Breakthrough Alliance Board Member More
  • Hoth Therapeutics: Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards More
  • OS Therapies: OST-HER2 Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma Program Update Following FDA End of Phase 2 Meeting More
  • Outlook Therapeutics: Requests Type A Meeting With FDA More
  • Transcend Therapeutics: New Data Demonstrating the Mechanism of Action of TSND-201 (methylone) for the Treatment of PTSD Published in Neuropsychopharmacology More

Amplify your impact. Maximize your investment. Brought to you by Big4Bio and PR Newswire

Financial News

  • BYTE51: Exclusive Pricing on Private Biotech & VC Intelligence More
  • Celularity: Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance More
  • Cognition Therapeutics: Closes $30 Million Registered Direct Offering to Two New Fundamental Institutional Investors, Including a Preeminent Global Investment Firm to Support Phase 3 Development of Zervimesine (CT1812) More
  • Novartis Plots 58 Layoffs in N.J. Amid Ongoing Efficiency Drive More
  • OS Therapies: Completes Exercise Inducement and Exchange Offer for All Remaining Outstanding Warrants Issued in Connection With December 2024 Financing More
  • Protara Therapeutics: Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) More
  • TG Therapeutics: Completion of Existing Share Repurchase Program and Authorization of New $100 Million Program More
  • The Big4Bio Podcast: Surviving and Thriving in the Long Biotech Winter Podcast
  • Zenas BioPharma and Royalty Pharma: Enter Into Obexelimab Funding Agreement for up to $300 Million More More
A single platform for private Biotech & VC intelligence. Reliable. Real-time. Affordable. BYTE51 - Exclusive pricing for Big4Bio Readers

Media/Misc Coverage

  • Fierce 50 of 2025 More
  • More on Merck, Bayer’s Verquvo Posting Perplexing Trial Fail in Patients With Stable HFrEF More More*
  • More on Merck Claiming Another Late-Stage Win for Oral Cholesterol Drug More* More*
  • Subscribe to LifeSci Startup for Updates on US Startups More

Revolutionize how clinical research gets done. From insight to action - connect, align, accelerate. The future starts here. Register now >>

Companies

DISCOVER COMPANIES
Big4Bio: NYC Life Science Company Directory
Locate a specific company or explore new companies in life science.
Explore our Company Directory
Provided courtesy of
BioPharmGuy Logo
Feature your company
Apply to have your company showcased by Big4Bio.
Apply Today
Wacker Biotech - We are your partner. Flexible, reliable delivery of your: pDNA - mRNA - LNP | Proteins | Live Microbials | Vaccines. Partner with a global  CDMO backed by a science-driven powerhouse. Better with WACKER >>

Career Center

Organizational Leader and Business Strategist Kyle Kinzie Named President & Partner, Hospitals & Healthcare Delivery Solutions at Slone Partners
Learn More  →
  • FEATURE: The Power of Peer Learning: Why Even Top Biotech Leaders Need Mentorship More
  • ICYMI: The Changing Landscape of Diagnostics More
  • ICYMI: CEO's Perspective: The Power of Pivoting More
  • ICYMI: What Defines Great Leadership? More
  • Longtime Novo Nordisk Exec Cites ‘Recent Shifts’ for His Departure; Rocket Pharma CFO to Resign More*
Biofuture - Reimagine the Future of Healthcare. | October 13-15, 2025 NYC. Produced by DEMY COLTON

Event Center

Note: Events may be in any Big4Bio region or virtual
15th Annual DPHARM, Sept 16-17
Learn More  →
  • Grant Engine Webinar - Mastering Funding in 2025 Sept 3
  • Hub and Specialty Pharmacy Models West (Promo Code 25B4B10 to save 10%) Sept 4-5
  • PCC West Pharmaceutical Compliance Congress Sept 4-5
  • Happy Hour Drinks and Bowling With ACROBiosystems Sept 5
  • Charles River Biotech Symposium September 8-10
  • LinkedIn Strategies for Scientists - Chaperone Webinar Sept 9
  • Philly Builds Bio+ 4th Annual Symposium for Life Science Innovation and Development Sept 9
  • AI Meets Amplification: Smarter PR Strategies for Life Sciences Companies Sept 10
  • International Life Sciences & Biotech Conference (Promo Code BIG4BIO to save 20%) Sept 10–11
  • CRAACO: Clinical Research as a Care Option Sept 15
  • Partnerships with Sites Sept 15
  • Venture Catalyst - Exploring Life Sciences VC in Los Angeles Sept 16
  • 15th Annual DPHARM Sept 16-17
  • LSX World Congress USA Sept 16-17
  • RESI Boston 2025 Sept 17
  • Discovery On Target Sept 22-25
  • Science to Strategy: Advanced Degrees in Consulting Sept 25
  • Life Sciences Future Sept 25-26
  • AI LA Life Summit 2025 (Exclusive Discount: BIG4BAIO) Sept 27
  • The MedTech Conference Oct 5-8
  • Fierce Biotech Week Oct 7-9
  • MedFuel/One Life Science/WOMEN IN BIO (Discount Code: Big4Bio) Oct 9
  • BioFuture Oct 13-14
  • 2025 Battle of the Bio\Tech Bands West Oct 21

SEE FULL EVENT SCHEDULE AT THE BIOCALENDAR

NYC Sponsors


Follow us

Spotlights       Get Featured       Company Directory      News       Contact       Subscribe

You are receiving this email because you signed up for one of our newsletters at Big4Bio.com, signed up at one of our partner or sponsor events, or given as a gift subscription by your firm or organization. Unsubscribe

Big4Bio:NYC, all rights reserved 2025

© 2025 Big4Bio, a division of BigBio Communications. All rights reserved.